Ledger.Open graph →
SEC Form D · filed September 3, 2014

BELLICUM PHARMACEUTICALS, INC

Offering
$94.4M
Sold
$94.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Thomas J. Farrell · Houston, TXExec · DirectorDavid M. Spencer · Houston, TXExecAnnemarie K. Moseley · Houston, TXExecKevin M. Slawin · Houston, TXDirectorDennis K. Stone · Pittsfield, MADirectorJames F. Brown · Houston, TXDirectorFrank M. Mcguyer · Houston, TXDirectorKen K. Moseley · Houston, TXExecThomas J. Farrell · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗